MovDisordV3, PascalFrancis, Curation, bibRecord, 000859

Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study

Identifieur interne : 000859 ( PascalFrancis/Curation ); précédent : 000858; suivant : 000860

Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study

Auteurs : Carlo Colosimo [Italie, Royaume-Uni] ; Yasushi Osaki [Royaume-Uni] ; Nicola Vanacore [Italie] ; Andrew J. Lees [Royaume-Uni]

Source :

Movement disorders [ 0885-3185 ] ; 2003.

RBID : Pascal:03-0380304

Descripteurs français

Pascal (Inist)
- Hypertension artérielle, Ophtalmoplégie supranucléaire, Progressif, Anatomopathologie, Facteur risque, Association morbide, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Concomitant disease, Human, Hypertension, Pathology, Progressive, Risk factor, Supranuclear ophthalmoplegia.

Abstract

It has been reported that up to 80% of patients clinically diagnosed as having progressive supranuclear palsy (PSP) may have arterial hypertension (HT). Because previous studies were performed on patients with presumed diagnosis of PSP, we tried to replicate these studies in a series of pathologically confirmed patients. Seventy-three patients with a neuropathological diagnosis of PSP autopsied at the Queen Square Brain Bank for Neurological Disorders in London were collected between 1989 and 1999. For the purpose of this study, patients were considered hypertensive if a blood pressure above 140/90 mm Hg was found in the clinical records. The prevalence of HT in PSP patients at the first and at the last visit during their neurological disease was compared with that found in a series of 21 normal controls who donated their brain to the same institution. Overall, 29 of 73 (39.7%) of the patients were recorded as having HT at the first visit during the disease course; this ratio increased to 42 of 73 (57.5%) at the last visit before death. When these figures were compared to the 21 normal controls (11 of 21 with HT, 52.4%), we were unable to find an increased prevalence of HT in PSP (odds ratio, 0.60; 95% confidence interval, 0.20-1.76). Therefore, HT does not represent an important clinical feature of this neurodegenerative disorder, although cerebrovascular disease can masquerade clinically as PSP.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 18`
A06				`@2 6`
A08	`01`	`1`	`ENG`	`@1 Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study`
A11	`01`	`1`		`@1 COLOSIMO (Carlo)`
A11	`02`	`1`		`@1 OSAKI (Yasushi)`
A11	`03`	`1`		`@1 VANACORE (Nicola)`
A11	`04`	`1`		`@1 LEES (Andrew J.)`
A14	`01`			`@1 Dipartimento di Scienze Neurologiche, Università La Sapienza @2 Rome @3 ITA @Z 1 aut. @Z 3 aut.`
A14	`02`			`@1 Queen Square Brain Bank for Neurological Disorders, Institute of Neurology @2 London @3 GBR @Z 1 aut. @Z 2 aut. @Z 4 aut.`
A20				`@1 694-697`
A21				`@1 2003`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000119840860130`
A44				`@0 0000 @1 © 2003 INIST-CNRS. All rights reserved.`
A45				`@0 16 ref.`
A47	`01`	`1`		`@0 03-0380304`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 It has been reported that up to 80% of patients clinically diagnosed as having progressive supranuclear palsy (PSP) may have arterial hypertension (HT). Because previous studies were performed on patients with presumed diagnosis of PSP, we tried to replicate these studies in a series of pathologically confirmed patients. Seventy-three patients with a neuropathological diagnosis of PSP autopsied at the Queen Square Brain Bank for Neurological Disorders in London were collected between 1989 and 1999. For the purpose of this study, patients were considered hypertensive if a blood pressure above 140/90 mm Hg was found in the clinical records. The prevalence of HT in PSP patients at the first and at the last visit during their neurological disease was compared with that found in a series of 21 normal controls who donated their brain to the same institution. Overall, 29 of 73 (39.7%) of the patients were recorded as having HT at the first visit during the disease course; this ratio increased to 42 of 73 (57.5%) at the last visit before death. When these figures were compared to the 21 normal controls (11 of 21 with HT, 52.4%), we were unable to find an increased prevalence of HT in PSP (odds ratio, 0.60; 95% confidence interval, 0.20-1.76). Therefore, HT does not represent an important clinical feature of this neurodegenerative disorder, although cerebrovascular disease can masquerade clinically as PSP.
C02	`01`	`X`		`@0 002B12B05B`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Hypertension artérielle @5 01`
C03	`01`	`X`	`ENG`	`@0 Hypertension @5 01`
C03	`01`	`X`	`SPA`	`@0 Hipertensión arterial @5 01`
C03	`02`	`X`	`FRE`	`@0 Ophtalmoplégie supranucléaire @5 04`
C03	`02`	`X`	`ENG`	`@0 Supranuclear ophthalmoplegia @5 04`
C03	`02`	`X`	`SPA`	`@0 Oftalmoplejía supranuclear @5 04`
C03	`03`	`X`	`FRE`	`@0 Progressif @5 05`
C03	`03`	`X`	`ENG`	`@0 Progressive @5 05`
C03	`03`	`X`	`SPA`	`@0 Progresivo @5 05`
C03	`04`	`X`	`FRE`	`@0 Anatomopathologie @5 07`
C03	`04`	`X`	`ENG`	`@0 Pathology @5 07`
C03	`04`	`X`	`SPA`	`@0 Anatomía patológica @5 07`
C03	`05`	`X`	`FRE`	`@0 Facteur risque @5 17`
C03	`05`	`X`	`ENG`	`@0 Risk factor @5 17`
C03	`05`	`X`	`SPA`	`@0 Factor riesgo @5 17`
C03	`06`	`X`	`FRE`	`@0 Association morbide @5 18`
C03	`06`	`X`	`ENG`	`@0 Concomitant disease @5 18`
C03	`06`	`X`	`SPA`	`@0 Asociación morbosa @5 18`
C03	`07`	`X`	`FRE`	`@0 Homme @5 20`
C03	`07`	`X`	`ENG`	`@0 Human @5 20`
C03	`07`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cardiovascular disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Oeil pathologie @5 45`
C07	`02`	`X`	`ENG`	`@0 Eye disease @5 45`
C07	`02`	`X`	`SPA`	`@0 Ojo patología @5 45`
C07	`03`	`X`	`FRE`	`@0 Oculomotricité syndrome @5 46`
C07	`03`	`X`	`ENG`	`@0 Oculomotor syndrome @5 46`
C07	`03`	`X`	`SPA`	`@0 Oculomotricidad síndrome @5 46`
C07	`04`	`X`	`FRE`	`@0 Système nerveux pathologie @5 47`
C07	`04`	`X`	`ENG`	`@0 Nervous system diseases @5 47`
C07	`04`	`X`	`SPA`	`@0 Sistema nervioso patología @5 47`
C07	`05`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 48`
C07	`05`	`X`	`ENG`	`@0 Central nervous system disease @5 48`
C07	`05`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 48`
C07	`06`	`X`	`FRE`	`@0 Tronc cérébral syndrome @5 49`
C07	`06`	`X`	`ENG`	`@0 Brain stem syndrome @5 49`
C07	`06`	`X`	`SPA`	`@0 Tallo encefalico sindrome @5 49`
C07	`07`	`X`	`FRE`	`@0 Encéphale pathologie @5 50`
C07	`07`	`X`	`ENG`	`@0 Cerebral disorder @5 50`
C07	`07`	`X`	`SPA`	`@0 Encéfalo patología @5 50`
C07	`08`	`X`	`FRE`	`@0 Maladie dégénérative @5 51`
C07	`08`	`X`	`ENG`	`@0 Degenerative disease @5 51`
C07	`08`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 51`
N21				`@1 265`
N82				`@1 PSI`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002462

Links to Exploration step

Pascal:03-0380304

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study</title>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Neurologiche, Università La Sapienza</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Osaki, Yasushi" sort="Osaki, Yasushi" uniqKey="Osaki Y" first="Yasushi" last="Osaki">Yasushi Osaki</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Vanacore, Nicola" sort="Vanacore, Nicola" uniqKey="Vanacore N" first="Nicola" last="Vanacore">Nicola Vanacore</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Neurologiche, Università La Sapienza</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0380304</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 03-0380304 INIST</idno>
<idno type="RBID">Pascal:03-0380304</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002462</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000859</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study</title>
<author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Neurologiche, Università La Sapienza</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Osaki, Yasushi" sort="Osaki, Yasushi" uniqKey="Osaki Y" first="Yasushi" last="Osaki">Yasushi Osaki</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Vanacore, Nicola" sort="Vanacore, Nicola" uniqKey="Vanacore N" first="Nicola" last="Vanacore">Nicola Vanacore</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Dipartimento di Scienze Neurologiche, Università La Sapienza</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Concomitant disease</term>
<term>Human</term>
<term>Hypertension</term>
<term>Pathology</term>
<term>Progressive</term>
<term>Risk factor</term>
<term>Supranuclear ophthalmoplegia</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Hypertension artérielle</term>
<term>Ophtalmoplégie supranucléaire</term>
<term>Progressif</term>
<term>Anatomopathologie</term>
<term>Facteur risque</term>
<term>Association morbide</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">It has been reported that up to 80% of patients clinically diagnosed as having progressive supranuclear palsy (PSP) may have arterial hypertension (HT). Because previous studies were performed on patients with presumed diagnosis of PSP, we tried to replicate these studies in a series of pathologically confirmed patients. Seventy-three patients with a neuropathological diagnosis of PSP autopsied at the Queen Square Brain Bank for Neurological Disorders in London were collected between 1989 and 1999. For the purpose of this study, patients were considered hypertensive if a blood pressure above 140/90 mm Hg was found in the clinical records. The prevalence of HT in PSP patients at the first and at the last visit during their neurological disease was compared with that found in a series of 21 normal controls who donated their brain to the same institution. Overall, 29 of 73 (39.7%) of the patients were recorded as having HT at the first visit during the disease course; this ratio increased to 42 of 73 (57.5%) at the last visit before death. When these figures were compared to the 21 normal controls (11 of 21 with HT, 52.4%), we were unable to find an increased prevalence of HT in PSP (odds ratio, 0.60; 95% confidence interval, 0.20-1.76). Therefore, HT does not represent an important clinical feature of this neurodegenerative disorder, although cerebrovascular disease can masquerade clinically as PSP.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>18</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>COLOSIMO (Carlo)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>OSAKI (Yasushi)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>VANACORE (Nicola)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>LEES (Andrew J.)</s1>
</fA11>
<fA14 i1="01"><s1>Dipartimento di Scienze Neurologiche, Università La Sapienza</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Queen Square Brain Bank for Neurological Disorders, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>694-697</s1>
</fA20>
<fA21><s1>2003</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000119840860130</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>16 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0380304</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>It has been reported that up to 80% of patients clinically diagnosed as having progressive supranuclear palsy (PSP) may have arterial hypertension (HT). Because previous studies were performed on patients with presumed diagnosis of PSP, we tried to replicate these studies in a series of pathologically confirmed patients. Seventy-three patients with a neuropathological diagnosis of PSP autopsied at the Queen Square Brain Bank for Neurological Disorders in London were collected between 1989 and 1999. For the purpose of this study, patients were considered hypertensive if a blood pressure above 140/90 mm Hg was found in the clinical records. The prevalence of HT in PSP patients at the first and at the last visit during their neurological disease was compared with that found in a series of 21 normal controls who donated their brain to the same institution. Overall, 29 of 73 (39.7%) of the patients were recorded as having HT at the first visit during the disease course; this ratio increased to 42 of 73 (57.5%) at the last visit before death. When these figures were compared to the 21 normal controls (11 of 21 with HT, 52.4%), we were unable to find an increased prevalence of HT in PSP (odds ratio, 0.60; 95% confidence interval, 0.20-1.76). Therefore, HT does not represent an important clinical feature of this neurodegenerative disorder, although cerebrovascular disease can masquerade clinically as PSP.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B12B05B</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Hypertension artérielle</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Hypertension</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Hipertensión arterial</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Ophtalmoplégie supranucléaire</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Supranuclear ophthalmoplegia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Oftalmoplejía supranuclear</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Progressif</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Progressive</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Progresivo</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Anatomopathologie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Pathology</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Anatomía patológica</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Association morbide</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Concomitant disease</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Asociación morbosa</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Oeil pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Oculomotricité syndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Oculomotor syndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Oculomotricidad síndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>47</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>47</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>47</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>48</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>48</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>48</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Tronc cérébral syndrome</s0>
<s5>49</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Brain stem syndrome</s0>
<s5>49</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Tallo encefalico sindrome</s0>
<s5>49</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>50</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>50</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>50</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>51</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>51</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>51</s5>
</fC07>
<fN21><s1>265</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000859 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000859 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:03-0380304
   |texte=   Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study

Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri